Skip to content

MeiraGTx Holdings plc MGTX Net Change in Cash

Net Change in Cash at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$153.1M-125%
Opko Health logo
Opko HealthOPK
-$27.18M-769%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$120.57M+492%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$33.19M+834%
ALN
Alnylam PharmaceuticalsALNY
$53.61M0.0%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$17.47M+68.0%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's net change in cash?
MeiraGTx Holdings plc (MGTX) reported net change in cash of $5.44M in Q1 2026.
How has MeiraGTx Holdings plc's net change in cash changed year-over-year?
MeiraGTx Holdings plc's net change in cash increased by 114.8% year-over-year, from -$36.83M to $5.44M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.